4//SEC Filing
Hindman Andrew A. 4
Accession 0001179110-20-002146
CIK 0001583107other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 7:08 PM ET
Size
4.5 KB
Accession
0001179110-20-002146
Insider Transaction Report
Form 4
Hindman Andrew A.
SVP, Chief Financial Officer
Transactions
- Tax Payment
Ordinary Shares
2020-02-20$25.90/sh−7,060$182,854→ 106,490 total
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001607965
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 7:08 PM ET
- Size
- 4.5 KB